Use of face masks in dermatology department during the
            <scp>COVID</scp>
            ‐19 outbreak

Goldust, Mohamad; Kroumpouzos, George; Murrell, Dédée F.; Jafferany, Mohammad; Lotti, Torello; Wollina, Uwe; Shivakumar, Swathi

doi:10.1111/dth.13521

Cited by 6 publications

(3 citation statements)

References 9 publications

(16 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, after a month that occurrence of the loose lockdown circumstances and probably worsening of acne during that time might have encouraged these patients to attend hospitals in May. It is a well‐established fact that global use of face masks is increased due to the control of spread of infection from asymptomatic carriers 25 . The enhanced flare of acne mechanica in the course of time may be another reason that can explain a significantly increasing number of patients with acne after 2 months of COVID‐19 pandemic 4,8 …”

Section: Discussionmentioning

confidence: 99%

Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of theCOVID‐19 pandemic

Kutlu

Metin

2020

Dermatologic Therapy

View full text Add to dashboard Cite

As an increasing number of COVID-19 cases, there were changes in the number of patients who attended the dermatology outpatient clinics. We aimed to investigate the change profiles of dermatologic diseases in the first and second months of the COVID-19 pandemic in Turkey by comparing with the corresponding period of the previous year. The total number and diagnosis of patients, who attended a tertiary care hospital for the dermatology outpatient clinic between 1 April 2020 and 31 May 2020, were included in this study. These data were compared with the corresponding period of the previous year. The percentage of the patients with scabies, contact dermatitis, psoriasis, pityriasis rosea, urticaria, and alopecia areata were statistically significantly increased a month after the occurrence of the COVID-19 pandemic, while the percentage of patients with scabies, alopecia areata, telogen effluvium, acne vulgaris, and xerosis cutis were statistically significantly increased 2 months after the occurrence of the COVID-19 pandemic (P < 0.05). An increase in the number of certain diseases such as urticaria and pityriasis rosea may indicate the risk of asymptomatic COVID-19 carriage in these patients. Polymerase chain reaction (PCR) and/or antibody-based further studies should be performed to explore whether certain dermatologic diseases are related to asymptomatic COVID-19 cases.

show abstract

Section: Discussionmentioning

confidence: 99%

Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of theCOVID‐19 pandemic

Kutlu

Metin

2020

Dermatologic Therapy

View full text Add to dashboard Cite

show abstract

“… 7 , 8 During this critical time, they have played a significant role in enhancing preventive measures, 9 , 10 , 11 even while facing the shortages of personal protective equipment (PPE) in the health care system. 12 , 13 , 14 …”

Section: Introductionmentioning

confidence: 99%

Global impact on dermatology practice due to the COVID-19 pandemic

Bhargava

Negbenebor

Sadoughifar

et al. 2021

Clinics in Dermatology

Self Cite

View full text Add to dashboard Cite

This contribution focuses on the effects of coronavirus disease 2019 (COVID-19) on dermatology practice. We discuss the impact on practice volume and procedures and on the considerable increase in teledermatology use. We also describe the important roles that dermatologists have played in enhancing infection prevention and on the frontline. During the crisis, dermatologists have faced the challenge of a shortage of resources, such as personal protective equipment, in the health care system. In addition, they have been involved in managing cutaneous manifestations related to COVID-19 and occupational disease caused by personal protective equipment. Dermatologists have made a diligent effort to identify melanoma and to ensure the treatment of high-risk skin cancers. Safety guidelines have been suggested to minimize the potential risks associated with the systemic use of immunosuppressant agents and immunomodulators in patients with severe inflammatory skin disease during the pandemic. Finally, social distancing necessitated that dermatology conferences take place virtually and teaching via e-learning increased.

show abstract

“…Dermatologists have played important roles in COVID-19 prevention and judicious management of skin disease during this critical period ( Bhargava et al, 2021c ; Goren et al, 2020a ; Goldust et al, 2020a ). They served on the frontline in several parts of the globe ( Bhargava et al, 2020b ; Zheng and Lai, 2020 ).…”

Section: Introductionmentioning

confidence: 99%